Evidence map›Paper›PMID 40018459›Full record

ArticleCureus2025

Percutaneous Right Ventricular Assist Device for Managing Decompensated Right Heart Failure in Pulmonary Arterial Hypertension.

Devon Kelley, Ahmed Abdelmonem, Ishan Abdullah, Watipa Makhumalo, Jalil E Ahari

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Devon KelleyInternal Medicine, George Washington University School of Medicine and Health Sciences, Washington DC, USA.
Ahmed AbdelmonemResearch, George Washington University School of Medicine and Health Sciences, Washington, USA.
Ishan AbdullahInternal Medicine, George Washington University School of Medicine and Health Sciences, Washington DC, USA.
Watipa MakhumaloPulmonary and Critical Care Medicine, George Washington University School of Medicine and Health Sciences, Washington DC, USA.
Jalil E AhariPulmonary and Critical Care Medicine, George Washington University School of Medicine and Health Sciences, Washington DC, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Management of pulmonary arterial hypertension (PAH) with concomitant decompensated right-sided heart failure refractory to conventional pharmacotherapy presents a significant and multifaceted medical challenge. Although extracorporeal membrane oxygenation has been proven as an effective emergency intervention for unresponsive cardiopulmonary failure, the alternative use of a right ventricular assist device (RVAD) holds promise in the appropriate setting. We present a case of RVAD use in a patient with life-threatening acute PAH who was successfully bridged through critical decompensation to discharge without the need for more invasive procedures.

Indexed as

extracorporeal membrane oxygenation (ecmo)heart failurepulmonary artery catheterpulmonary hypertensionright ventricular assist device (rvad)

Identifiers

PMID40018459
PMCPMC11865928

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.